BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15090034)

  • 1. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness.
    Ransome MI; Goldshmit Y; Bartlett PF; Waters MJ; Turnley AM
    Eur J Neurosci; 2004 Apr; 19(8):2069-79. PubMed ID: 15090034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2.
    Ransome MI; Turnley AM
    Neuroscience; 2005; 132(3):673-87. PubMed ID: 15837129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
    Turnley AM; Faux CH; Rietze RL; Coonan JR; Bartlett PF
    Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and SOCS2 regulation of neuronal differentiation: possible role in mental function.
    Turnley AM
    Pediatr Endocrinol Rev; 2005 Mar; 2(3):366-71. PubMed ID: 16429112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of SOCS2 on neuronal differentiation and morphology.
    Scott HJ; Stebbing MJ; Walters CE; McLenachan S; Ransome MI; Nichols NR; Turnley AM
    Brain Res; 2006 Jan; 1067(1):138-45. PubMed ID: 16360125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signalling-2 and epidermal growth factor regulate neurite outgrowth of cortical neurons.
    Goldshmit Y; Greenhalgh CJ; Turnley AM
    Eur J Neurosci; 2004 Nov; 20(9):2260-6. PubMed ID: 15525267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of SOCS2 in growth hormone actions.
    Turnley AM
    Trends Endocrinol Metab; 2005 Mar; 16(2):53-8. PubMed ID: 15734145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone promotes proliferation of adult neurosphere cultures.
    McLenachan S; Lum MG; Waters MJ; Turnley AM
    Growth Horm IGF Res; 2009 Jun; 19(3):212-8. PubMed ID: 18976947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock your SOCS off!
    Leroith D; Nissley P
    J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Socs2 expression causes the high-growth phenotype in mice.
    Horvat S; Medrano JF
    Genomics; 2001 Mar; 72(2):209-12. PubMed ID: 11401434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone signaling and hippocampal neurogenesis: insights from genetic models.
    Ransome MI; Turnley AM
    Hippocampus; 2008; 18(10):1034-50. PubMed ID: 18566962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.
    Kishi N; Macklis JD
    Mol Cell Neurosci; 2004 Nov; 27(3):306-21. PubMed ID: 15519245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
    J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic STAT proteins: regulation of somatostatin neurones by growth hormone via STAT5b.
    Bennett E; McGuinness L; Gevers EF; Thomas GB; Robinson IC; Davey HW; Luckman SM
    J Neuroendocrinol; 2005 Mar; 17(3):186-94. PubMed ID: 15796771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
    Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5.
    Sims NA; Clément-Lacroix P; Da Ponte F; Bouali Y; Binart N; Moriggl R; Goffin V; Coschigano K; Gaillard-Kelly M; Kopchick J; Baron R; Kelly PA
    J Clin Invest; 2000 Nov; 106(9):1095-103. PubMed ID: 11067862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.